JesseJamesVeenstraMDPhD, MS
Dermatology • Detroit, MISenior Staff Dermatologist at Henry Ford Health System
Dr. Veenstra is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3031 W Grand Blvd
Ste 800
Detroit, MI 48202Phone+1 313-916-2151Fax+1 313-916-5334
Education & Training
Henry Ford Health/Henry Ford HospitalResidency, Dermatology, 2016 - 2019
Ascension St John HospitalInternship, Transitional Year, 2015 - 2016
Wayne State University School of MedicineClass of 2015
Wayne State UniversityPhD- Wayne State UniversityMS, Medical Research
Certifications & Licensure
MI State Medical License 2015 - 2026- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Chief Resident Henry Ford Dermatology
- Young Investigator Award American Association of Immunologists, 2015
- Distinction in Biomedical Research Wayne State University School of Medicine, 2015
- Join now to see all
Publications & Presentations
PubMed
- 22 citationsA clinical and biological review of keratoacanthoma.Aaron Tisack, A Fotouhi, Chelsea Fidai, Ben J. Friedman, David M. Ozog
The British Journal of Dermatology. 2021-04-16 - 27 citationsAntecedent immunosuppressive therapy for immune-mediated inflammatory diseases in the setting of a COVID-19 outbreak.Jesse Veenstra, Connor R Buechler, Gabrielle Robinson, Stephanie Chapman, Madeline Adelman
Journal of the American Academy of Dermatology. 2020-12-01 - 4 citationsBattling Neuropathic Scar Pain With Botulinum ToxinAndrew Schuler, Jesse Veenstra, David M. Ozog
Journal of Drugs in Dermatology. 2019-09-01
Press Mentions
Some Immunosuppressants Do Not Increase COVID-19 Risk: ScientistsSeptember 15th, 2020- Immunosuppressive Drugs for Psoriasis and RA Do Not Increase Risk for COVID-19: Henry Ford StudySeptember 14th, 2020
- COVID-19 and Immunosuppressive Therapies: Q&A with Dr VeenstraAugust 13th, 2020
Grant Support
- Ruth L. Kirschstein F30 FellowshipNational Institute on Aging2011–2016
- The Ruth L. Kirschstein NRSA Institutional Research Training Grant (T32)National Cancer Institute2010–2011
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
